In this study, we found that serum PAI-1, adiponectin, resistin, and RBP4 levels were significant biomarkers for predicting the future progression to prediabetes or type 2 diabetes after adjusting for parameters related to inflammation and insulin resistance. This evidence concerns the gene ADIPOQ and Insulin resistance.